Insider trades
Karen Akinsanya, Director of Nautilus Biotechnology NAUT, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $44.1K. The latest trade was on 06/18.
Karen Akinsanya
Director
- Company
- Nautilus Biotechnology NAUT
- First filing
- 23/02/10
- Trades
- 21 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- −$44.1K
- Last trade
- 06/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
SchrodingerSDGR | Open-market sale10b5-1 plan | 03/05 | 03/06 | 1,366 sh | $12.90 | $17,621.4 | −1.9% |
SchrodingerSDGR | Open-market sale10b5-1 plan | 03/02 | 03/03 | 2,206 sh | $11.99 | $26,449.94 | −3.0% |
SDGR | Open-market sale10b5-1 plan | 25/04/14 | 25/04/15 | 16,723 sh3 trades | $25.09avg. | $419,546.58 | −51.7% |
